Skip to main content

UnitedHealth Group cash flow statement

  • UNH · NYSE
  • Insurance
  • Managed Health Care
  • S&P 500
$407.46+0.58%Close 13 Nov 2026

In fiscal 2025 (the year to 31 Dec 2025), UnitedHealth Group generated $19.70B of operating cash flow and $16.07B of free cash flow, after $3.62B of capital expenditure.

From UnitedHealth Group's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 31 Dec 2025. TTM is the last four reported quarters added up.

Annual

UnitedHealth Group cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$4.65B$2.98B$3.82B$4.63B$5.14B$5.53B$5.63B$5.62B$5.81B$7.02B$10.56B$11.99B$13.84B$15.40B$17.29B$20.12B$22.38B$14.40B$12.06B$15.88B
Depreciation & amortization$796.0M$981.0M$991.0M$1.06B$1.12B$1.31B$1.38B$1.48B$1.69B$2.06B$2.25B$2.43B$2.72B$2.89B$3.10B$3.40B$3.97B$4.10B$4.36B$4.26B
Stock-based compensation$505.0M$305.0M$334.0M$326.0M$401.0M$421.0M$331.0M$364.0M$406.0M$485.0M$597.0M$638.0M$697.0M$679.0M$800.0M$925.0M$1.06B$1.02B$971.0M$1.02B
Operating cash flow$5.88B$4.24B$5.63B$6.27B$6.97B$7.16B$6.99B$8.05B$9.74B$9.79B$13.60B$15.71B$18.46B$22.17B$22.34B$26.21B$29.07B$24.20B$19.70B$26.20B
Operating cash flow margin7.8%5.2%6.5%6.7%6.8%6.5%5.7%6.2%6.2%5.3%6.8%6.9%7.6%8.6%7.8%8.1%7.8%6.0%4.4%5.8%
Capital expenditures$871.0M$791.0M$739.0M$878.0M$1.07B$1.07B$1.31B$1.52B$1.56B$1.71B$2.02B$2.06B$2.07B$2.05B$2.45B$2.80B$3.39B$3.50B$3.62B$3.37B
Acquisitions$270.0M$4.01B$486.0M$2.32B$1.84B$6.28B$362.0M$1.92B$16.16B$1.76B$2.13B$6.00B$8.34B$7.14B$4.82B$21.46B$10.14B$13.41B$4.51B$1.61B
Free cash flow$5.01B$3.45B$4.89B$5.39B$5.90B$6.08B$5.68B$6.53B$8.18B$8.09B$11.57B$13.65B$16.39B$20.12B$19.89B$23.40B$25.68B$20.70B$16.07B$22.83B
Free cash flow margin6.6%4.2%5.6%5.7%5.8%5.5%4.6%5.0%5.2%4.4%5.8%6.0%6.8%7.8%6.9%7.2%6.9%5.2%3.6%5.1%
Free cash flow per share$3.68$2.78$4.14$4.77$5.43$5.82$5.56$6.62$8.46$8.36$11.75$13.89$16.97$20.94$20.80$24.64$27.38$22.29$17.65$25.18
Dividends paid$40.00M$37.00M$36.00M$449.0M$651.0M$820.0M$1.06B$1.36B$1.79B$2.26B$2.77B$3.32B$3.93B$4.58B$5.28B$5.99B$6.76B$7.53B$7.92B$8.17B
Gross share repurchases$6.60B$2.68B$1.80B$2.52B$2.99B$3.08B$3.17B$4.01B$1.20B$1.28B$1.50B$4.50B$5.50B$4.25B$5.00B$7.00B$8.00B$9.00B$5.54B$5.03B
Stock issuance proceeds$712.0M$299.0M$282.0M$272.0M$381.0M$1.08B$598.0M$462.0M$402.0M$429.0M$688.0M$838.0M$1.04B$1.44B$1.35B$1.25B$1.35B$1.85B$827.0M$623.0M
Net share repurchases$5.89B$2.38B$1.52B$2.25B$2.61B$2.01B$2.57B$3.55B$798.0M$851.0M$812.0M$3.66B$4.46B$2.81B$3.65B$5.75B$6.65B$7.15B$4.72B$4.41B
Cash interest paid$553.0M$621.0M$527.0M$509.0M$472.0M$600.0M$724.0M$644.0M$639.0M$1.05B$1.13B$1.41B$1.63B$1.70B$1.65B$1.95B$3.04B$3.59B$4.03B—
Free cash flow after SBC$4.50B$3.14B$4.55B$5.07B$5.50B$5.66B$5.35B$6.16B$7.78B$7.61B$10.98B$13.01B$15.70B$19.44B$19.09B$22.48B$24.62B$19.69B$15.10B$21.81B

Quarterly

UnitedHealth Group cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$5.46B−$1.41B$4.22B$6.05B$5.54B$6.29B$3.41B$2.35B$10.00M$6.28B$5.48B$4.11B
Depreciation & amortization$974.0M$997.0M$1.02B$1.04B$1.04B$1.06B$1.08B$1.10B$1.12B$1.03B$1.04B$1.07B
Stock-based compensation$208.0M$372.0M$222.0M$237.0M$187.0M$375.0M$197.0M$223.0M$176.0M$348.0M$276.0M$219.0M
Operating cash flow−$5.19B$1.14B$6.75B$13.95B$2.37B$5.46B$7.19B$5.95B$1.11B$8.91B$11.05B$5.12B
Operating cash flow margin−5.5%1.1%6.8%13.8%2.4%5.0%6.4%5.3%1.0%8.0%9.9%4.5%
Capital expenditures$959.0M$743.0M$853.0M$991.0M$912.0M$898.0M$886.0M$890.0M$948.0M$763.0M$799.0M$859.0M
Acquisitions$1.75B$3.01B$25.00M$8.64B$1.73B$702.0M$32.00M$3.70B$73.00M$0.00$98.00M$1.44B
Free cash flow−$6.15B$401.0M$5.89B$12.95B$1.46B$4.56B$6.30B$5.05B$160.0M$8.15B$10.25B$4.26B
Free cash flow margin−6.5%0.4%6.0%12.8%1.4%4.2%5.6%4.5%0.1%7.3%9.2%3.8%
Free cash flow per share−$6.60$0.43$6.35$13.93$1.57$4.97$6.93$5.57$0.18$8.95$11.32$4.73
Dividends paid$1.74B$1.73B$1.94B$1.94B$1.93B$1.91B$2.00B$2.00B$2.00B$2.00B$2.09B$2.08B
Gross share repurchases$1.50B$3.07B$0.00$956.0M$4.97B$3.00B$2.54B$0.00$0.00$0.00$1.65B$3.38B
Stock issuance proceeds$314.0M$486.0M$258.0M$867.0M$235.0M$360.0M$221.0M$222.0M$24.00M$231.0M$128.0M$240.0M
Net share repurchases$1.19B$2.59B−$258.0M$89.00M$4.74B$2.64B$2.32B−$222.0M−$24.00M−$231.0M$1.52B$3.15B
Free cash flow after SBC−$6.36B$29.00M$5.67B$12.72B$1.27B$4.18B$6.11B$4.83B−$16.00M$7.80B$9.98B$4.04B

The main figures as JSON and plain text. See data and methodology.

UNH in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.